Meeting Abstracts of the 1st Fragile X International Congress

PMC · DOI:10.1186/s13023-025-03574-x·April 24, 2025

Meeting Abstracts of the 1st Fragile X International Congress

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes14

MSH3 MAPT FMR1-AS1 NEFL FMR1 UPF3A H3P6 UPF1 FAN1 UPF2 AMH USE1 GFAP UPF3B

Proteins14

Species1

Homo sapiens(human · species)

Chemicals15

metformin cortisol purine minocycline lipid Glutathione ATP glucose CBD sphingolipid melatonin 1H Creatine sertraline N-acetyl-aspartate

Diseases60

fatigue Learning Disability falls anxiety and depression disorders emotional disorders FXPAC chronic fatigue genetic condition balance disturbances Sleep disturbances autistic spectrum disorder DD Cerebral Palsy metabolic syndrome neurodegeneration FXPOI FM X-linked neurodevelopmental disorder ODD Klinefelter syndrome Prader Willi Anxiety neuroinflammation X-linked dominant disorder ASD dysmorphism ALPS behavioral difficulties Deafness dementia glymphatic system parkinsonism eating disorders glymphatic dysfunction gait ataxia depressive symptoms chronic pain Social anxiety excessive joint laxity Problems with cognition neuropathy X-chromosome disorders Communication Disorders Sleep apnea developmental disabilities fragile x syndrome malformations neurodevelopmental problems Tremor Rare Diseases ataxia hypertension Fragile X and other intellectual disabilities death Angelman hypotonia toxicity ADHD agitation fibromyalgia

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsGenetics and Neurodevelopmental Disorders · Adolescent and Pediatric Healthcare